SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences - Quaterly Results

14 Feb 2025 Evaluate
With no major difference for the quarter endedDecember 2024 , the total revenue stood at Rs. 2077.94  millions.A slender decline of -13.17% was recorded to Rs. 193.25  millions from Rs. 222.57 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 358.07 millions from 368.79 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2077.94 2017.78 2.98 6147.86 6116.72 0.51 8066.66 6906.21 16.80
Other Income 18.64 4.24 339.62 32.33 16.39 97.25 21.77 25.74 -15.42
PBIDT 358.07 368.79 -2.91 1115.82 1129.42 -1.20 1480.48 1372.25 7.89
Interest 49.09 31.79 54.42 147.12 117.13 25.60 153.60 82.23 86.79
PBDT 308.98 337.00 -8.31 968.70 1012.29 -4.31 1326.88 1290.02 2.86
Depreciation 46.18 41.42 11.49 132.21 126.75 4.31 170.17 222.81 -23.63
PBT 262.80 295.58 -11.09 836.49 885.54 -5.54 1156.71 1067.21 8.39
TAX 69.55 73.01 -4.74 216.89 224.63 -3.45 295.36 270.16 9.33
Deferred Tax 30.05 1.03 2817.48 32.39 33.92 -4.51 31.66 -11.94 -365.16
PAT 193.25 222.57 -13.17 619.60 660.91 -6.25 861.35 797.05 8.07
Equity 100.28 100.28 0.00 100.28 100.28 0.00 100.28 96.94 3.45
PBIDTM(%) 17.23 18.28 -5.72 18.15 18.46 -1.70 18.35 19.87 -7.63

Gufic Biosciences Share Price

306.05 4.85 (1.61%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×